骨质疏松症的共病研究与早期筛查  

Comorbidities of Osteoporosis:Recent Advances and Early Screening

作　　者：魏戌[1,2] 刘宁 章轶立 韩涛 孙凯[1,2] 齐保玉 陈忻 秦晓宽[1] 高景华 谢雁鸣 朱立国[1,2] WEI Xu;LIU Ning;ZHANG Yili;HANTao;SUN Kai;QI Baoyu;CHEN Xin;QIN Xiaokuan;GAO Jinghua;XIE Yanming;ZHU Liguo(Wangjing Hospital of Chinese Academy of Traditional Chinese Medicine,Beijing 100102,China;Beijing Institute of Orthopaedical Traumatology of the Integrating of Traditional and Western Medicine,Beijing 100700,China;School of Traditional Chinese Medicine&School of Integrated Chinese and Western Medicine,Nanjing University of Chinese Medicine,Nanjing 210023,China;Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China)

机构地区：[1]中国中医科学院望京医院,北京市100102 [2]北京市中西医结合骨伤研究所,100700 [3]南京中医药大学中医学院·中西医结合学院,江苏省南京市210023 [4]中国中医科学院中医临床基础医学研究所,北京市100700

出　　处：《中国全科医学》2022年第35期4369-4374,共6页Chinese General Practice

基　　金：国家中医药管理局传承创新团队项目(ZYYCTXD-C-202003);中国中医科学院科技创新工程重大攻关项目(CI2021A02013);中国中医科学院循证医学中心业务研究室主任专项(2020YJSZX-4);中国中医科学院优秀青年科技人才(创新类)培养专项(ZZ13-YQ-039)。

摘　　要：骨质疏松症患者常共患多种疾病,涉及内分泌、循环、呼吸、泌尿、免疫、骨骼肌肉、神经等多系统疾病,共病发生率较高,且这些共病可能会加重骨质疏松症,从而增加骨质疏松性骨折发生的风险,严重影响患者生活质量,同时使疾病管理更加复杂,给家庭和社会带来沉重负担。目前对于骨质疏松症共病的研究较为缺乏,现有的研究策略在共因、共防、共治方面难以有效指导临床医生开展共病管理。鉴于此,建议引入多学科综合治疗(MDT)理念,加强骨质疏松症相关共病及其致病机制的认识,对于可能合并骨质疏松症的患者需尽早筛查,一旦发现骨量减少、骨质疏松,应积极进行防治以降低骨折风险,早筛、早诊、早治,实现骨质疏松症共病的共防、共治。Comorbidities are highly prevalent in osteoporosis patients,including endocrine,circulatory,respiratory,urinary,immune,musculoskeletal,and neurological diseases,which may aggravate osteoporosis,increase the risk of osteoporotic fracture,and seriously affect the quality of patient’s life,bringing more challenges to associated clinical management,and imposing a heavy burden on the families and society.There is still a lack of studies on comorbidities of osteoporosis,and the existing research strategies are inadequate to support clinicians to carry out comorbidity management in terms of understanding the causes of osteoporosis and associated comorbidities,and delivering interventions for prevention and treatment of both of them.In view of this,it is suggested to use multidisciplinary integrated treatment,and strengthen the understanding of osteoporosis related comorbidities and their pathogenesis.Moreover,the screening for osteoporosis in people with possible osteoporosis risk should be performed as early as possible,and actions should be taken actively to reduce the risk of fracture in those who are found with osteopenia or osteoporosis.Early screening,diagnosis and treatment are necessary to realize the prevention and treatment of osteoporosis and associated comorbidities.

关 键 词：骨质疏松 共病现象 骨质疏松性骨折 诊断 发病机制 多学科综合治疗 早期筛查 

分 类 号：R681[医药卫生—骨科学]